Fierce ADC Battlefield… Celltrion’s Bet Is on ‘biobetter’
Celltrion, which has entered the rapidly emerging field of antibody–drug conjugates (ADCs), is seeking to differentiate itself with…
biobetter
1 개의 기사가 있습니다.